Dopamine agonists (e.g. pramipexole, ropinirole, rotigotine) used to be a first-line treatment for restless legs syndrome (RLS) but after more than two decades of use in this condition, it is apparent that they should no longer be used to treat RLS due to risk of augmentation. However, the second most worrisome effect of these drugs flies under the radar: impulse control disorders.

Andy Berkowski, MD of ReLACS Health describes impulse control disorders and how they can be caused by treatment with dopamine agonists for RLS.

You may read more about why dopamine agonists are bad for RLS in A ReLACSing blog:
[ Ссылка ]

свернуть